CTA
TECH icon

Colonial Trust Advisors’s Bio-Techne TECH Stock Holding History

Colonial Trust Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$211 – 1005
2024
Q1 		$211 Hold
3
– – ﹤0.01% 978
2023
Q4 		$231 Buy
3
+1
+50% +$66 ﹤0.01% 857
2023
Q3 		$136 Buy
+2
New +$158 ﹤0.01% 895

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Colonial Trust Advisors's TECH Position: Q2 2024 in Review

Colonial Trust Advisors sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 3 shares — an estimated $211 sold.

Colonial Trust Advisors first reported a position in TECH in Q3 2023 and held it in 3 quarters. The position peaked at $231 in Q4 2023. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

  • Colonial Trust Advisors reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 3 Bio-Techne shares in Q2 2024, an estimated $211.
  • Colonial Trust Advisors first reported a position in Bio-Techne in Q3 2023 and held it in 3 quarters.
  • Colonial Trust Advisors's Bio-Techne position peaked at $231 in Q4 2023.
  • 572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Colonial Trust Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.